Correlation between depressive symptom and executive function decline in amyloid positive mild cognitive impairment: Neuropsychiatry and behavioral neurology/Mild cognitive impairment/Early symptomatic disease. (7th December 2020)
- Record Type:
- Journal Article
- Title:
- Correlation between depressive symptom and executive function decline in amyloid positive mild cognitive impairment: Neuropsychiatry and behavioral neurology/Mild cognitive impairment/Early symptomatic disease. (7th December 2020)
- Main Title:
- Correlation between depressive symptom and executive function decline in amyloid positive mild cognitive impairment
- Authors:
- Choo, IL Han
Chung, Ji Yeon
Chong, Ari
Ha, Jung‐Min
Choi, Yu Yong
Kim, Hoowon - Abstract:
- Abstract: Background: V Depression is a risk factor of Alzheimer's disease dementia. We aimed to explore the correlation between depressive symptom and neuropsychological test results in mild cognitive impairment by amyloid positivity. Method: Sixty‐eight individuals with MCI were recruited. All participants received a Clinical Dementia Rating score of 0.5 and met the Petersen's criteria. Comprehensive neuropsychological assessment was performed using the SNSB II. The [18F]Florbetaben PET and MRI scans were performed. T1‐weighted MR 3D volumes were acquired for co‐registration with PET. All participants underwent Geriatric depression scale (GDS). Participants were classified as amyloid positive when the mean cortical SUVR was 1.20 and over. Correlation analyses between GDS score and each neuropsychological test standard score (z‐score based on age‐, education‐, and gender specific normative information) were performed. Result: Significant negative correlation between GDS score and Rey Complex Figure Test Copy z score was found in all MCI participants (r = ‐0.299, p = 0.013). For amyloid positive MCI group (n = 30), we found GDS scores were significantly correlated with Rey Complex Figure Test Copy z score (r = ‐0.364, p = 0.048) and Trail Making Test A z score (r = ‐0.473, p = 0.008). However, for amyloid negative MCI group (n = 39), there was no significant correlation. Conclusion: Our results suggest that amyloid positive MCI patients have significant correlation betweenAbstract: Background: V Depression is a risk factor of Alzheimer's disease dementia. We aimed to explore the correlation between depressive symptom and neuropsychological test results in mild cognitive impairment by amyloid positivity. Method: Sixty‐eight individuals with MCI were recruited. All participants received a Clinical Dementia Rating score of 0.5 and met the Petersen's criteria. Comprehensive neuropsychological assessment was performed using the SNSB II. The [18F]Florbetaben PET and MRI scans were performed. T1‐weighted MR 3D volumes were acquired for co‐registration with PET. All participants underwent Geriatric depression scale (GDS). Participants were classified as amyloid positive when the mean cortical SUVR was 1.20 and over. Correlation analyses between GDS score and each neuropsychological test standard score (z‐score based on age‐, education‐, and gender specific normative information) were performed. Result: Significant negative correlation between GDS score and Rey Complex Figure Test Copy z score was found in all MCI participants (r = ‐0.299, p = 0.013). For amyloid positive MCI group (n = 30), we found GDS scores were significantly correlated with Rey Complex Figure Test Copy z score (r = ‐0.364, p = 0.048) and Trail Making Test A z score (r = ‐0.473, p = 0.008). However, for amyloid negative MCI group (n = 39), there was no significant correlation. Conclusion: Our results suggest that amyloid positive MCI patients have significant correlation between depressive symptoms and executive function decline. … (more)
- Is Part Of:
- Alzheimer's & dementia. Volume 16(2020)Supplement 6
- Journal:
- Alzheimer's & dementia
- Issue:
- Volume 16(2020)Supplement 6
- Issue Display:
- Volume 16, Issue 6 (2020)
- Year:
- 2020
- Volume:
- 16
- Issue:
- 6
- Issue Sort Value:
- 2020-0016-0006-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2020-12-07
- Subjects:
- Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/alz.037745 ↗
- Languages:
- English
- ISSNs:
- 1552-5260
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21900.xml